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Edited by Jesus AvilaAbstract Chromosome segregation in mitosis is orchestrated
by dynamic interaction between spindle microtubule and the
kinetochore. Our recent ultrastructural studies demonstrated a
dynamic distribution of TTK, from the kinetochore to the
centrosome, as cell enters into anaphase. Here, we show that a
centrosomal protein TACC2 is phosphorylated in mitosis by
TTK signaling pathway. TACC2 was pulled down by wild type
TTK but not kinase death mutant, suggesting the potential
phosphorylation-mediated interaction between these two pro-
teins. Our immunoﬂuorescence studies revealed that both TTK
and TACC2 are located to the centrosome. Interestingly,
expression of kinase death mutant of TTK eliminated the
centrosomal localization of TACC2 but not other centrosomal
proteins such as c-tubulin and NuMA, a phenotype seen in TTK-
depleted cells. In these centrosomal TACC2-liberated cells,
chromosomes were lagging and mis-aligned. In addition, the
distance between two centrosomes was markedly reduced,
suggesting that centrosomal TACC2 is required for mitotic
spindle maintenance. The inter-relationship between TTK and
TACC2 established here provides new avenue to study centro-
some and spindle dynamics underlying cell divisional control.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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TACC21. Introduction
Chromosome movements during mitosis are orchestrated by
the interaction of spindle microtubules with a specialized
chromosome domain located within the centromere (e.g., [1]).
This specialized proteinous region, called the kinetochore, is
responsible for mitotic microtubule-centromere association.
Spatial and temporal control of microtubule dynamics is es-
sential to ensure successful cell division. Centrosomes and ki-
netochores are primary regulators of microtubule dynamics in
mitotic cells. Several recent studies revealed that protein kinase
TTK interacts with kinetochore associated motor protein* Corresponding author. Fax: +86-551-3606304.
E-mail address: yaoxb@ustc.edu.cn (X. Yao).
Abbreviations: TACC, transforming acidic coiled-coil; SDS–PAGE,
SDS–polyacrylamide gel electrophoresis; DAPI, 4,6-diamidino-2-
phenylindole
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revealed the localization of TTK to corona ﬁbers of the ki-
netochore in prometaphase cells but relocated to centrosome
upon the chromosomal alignment at the equator [4]. Dynamic
localization of TTK supports the notion in which TTK par-
ticipates in centrosome-based spindle checkpoint (e.g., [4,5]).
TTK is a mammalian homolog of conserved Mps1 family
members that are expressed in all proliferating cells and tissues
[6,7], consistent with its function in cell cycle progression. In all
these Mps1 family members, the C-terminal catalytic domains
show a high degree of sequence similarity [8]. Furthermore,
both yeast and mammalian Mps1 kinases phosphorylate ser-
ine/threonine as well as tyrosine residues [7,9,10]. It has been
shown that TTK1 (hMPS1) is required for human cells to
undergo checkpoint arrest in response to microtubule depo-
lymerization. In contrast, centrosome (re-)duplication as well
as cell division occurs in the absence of hMps1 [11]. While
functional and ultrastructural studies support an essential role
of TTK in mitotic checkpoint control, at both kinetochore and
centrosome, in mammalian cells, the molecular mechanisms
underlying TTK function in the mitotic centrosome are
unknown.
Centrosomes are the main microtubule organizing centers in
animal cells. In addition, centrosomes help to organize the
poles of the mitotic spindle that is responsible for partitioning
the chromosomes equally between the two daughter cells
during cell division (e.g., [12]). It has been shown that the loss
of a spindle checkpoint control could lead to both genetic in-
stability and centrosomal abnormalities. However, it is unclear
how spindle checkpoint signaling governs mitotic centrosomal
dynamics.
Members of the transforming acidic coiled-coil (TACC)
family of proteins have all been implicated in centrosome dy-
namics [12,13]. There are at least three members of TACC
proteins in human cells. The three human TACC genes map to
the chromosomal regions 8p11, 10q26 and 4p16, respectively
(e.g., [13]). These chromosomal regions have been re-arranged
in certain cancers, in particular breast cancer. Although there
are three TACC proteins in human, their tissue-speciﬁc ex-
pression and distinct spatial–temporal regulation of subcellu-
lar distribution argue for functional speciﬁcity among the three
proteins. Interestingly, TACC2 has also recently been identi-
ﬁed as a potential tumor suppressor in a search for genes
diﬀerentially expressed between malignant mammary epithelial
cells and their immediate non-malignant progenitors [14].ation of European Biochemical Societies.
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progressed from a benign to a malignant phenotype of breast
epithelial cells [14].
To better address the function of TTK in human cells, we
have searched for proteins downstream from TTK signaling
in HeLa cells. We show that the protein phosphorylation of
TACC2 was minimized when TTK kinase death mutant was
expressed. Our immunoﬂuorescence study veriﬁed the co-
localization of TTK with TACC2 in the centrosomes of
mitotic cells. Signiﬁcantly, loss of TTK activity nails down
the centrosomal localization of TTK. The loss of TACC2
shortened the distance between the two centrosomes and
perturbed chromosome segregation. Thus, we proposed that
TTK exerts its centrosome-based function by modulating
TACC2 in mitosis.2. Materials and methods
2.1. Cell culture
HeLa and 293T cells, from American Type Culture Collection
(Rockville, MD), were maintained as subconﬂuent monolayers in
DMEM (Invitrogen; Carlsbad, CA) with 10% FBS (Hyclone, UT) and
100 U/ml penicillin plus 100 lg/ml streptomycin (Invitrogen).
2.2. Transient transfection and immunoprecipitation
HeLa cells were grown to 75% conﬂuency in DMEM with 10%
FBS at 37 C in 10% CO2 and were exposed to 100 ng/ml noco-
dazole (Sigma Chemical Inc.) for 20 h. Mitotic shake-oﬀ was con-
ducted to collect mitotic cells as described previously (e.g., [15,16]).
In some cases, mitotic cells were collected and plated in nocodazole-
free media for 4 h to enter early G1 (as judged by loss of cyclin B
protein). These mitotic and G1 cells were then lysed in buﬀer (50
mM HEPES, pH 7.4, 150 mM NaCl, 2 mM EGTA, 0.1% Triton X-
100, 1 mM phenylmethylsulfonyl ﬂuoride, 10 lg/ml leupeptin and 10
lg/ml pepstatin A), respectively. Lysates were clariﬁed by centrifu-
gation at 16 000 g for 10 min at 4 C and then incubated with anti-
GFP antibody (BD Biosciences) bound protein-A/G beads (Pierce
Chemical, IL). After rotating at 4 C for 2 h, beads were washed ﬁve
times with lysis buﬀer and then boiled in protein sample buﬀer for 2
min. After SDS–polyacrylamide gel electrophoresis (SDS–PAGE),
proteins were transferred to nitrocellulose membrane. The membrane
was divided into three strips and probed with antibodies against the
TACC2, TTK (Zymed), and b-tubulin (Sigma Chemicals), respec-
tively. Immunoreactive signals were detected with ECL kit (Pierce
Chemical) and visualized by autoradiography on Kodak BioMAX
ﬁlm.
2.3. Suppression of TTK activity by SiRNA mediated protein
knock-down or kinase death mutant
RNA interference was carried out as described previously (e.g., [17]).
A 21-mer siRNA oligonucleotide, corresponding to nucleotides 1077–
1097 from the start codon of TTK, was synthesized by Dharmacon
Inc. (Lafayette, CO). SiRNA was delivered into cells by pre-mixing
Lipofectamine 2000 (Invitrogen) with siRNA oligonucleotide in Opti-
MEM (Invitrogen). The plates were replaced with fresh medium 16 h
later and coverslips were usually harvested 36–48 h after transfection.
A kinase-death version of TTK (TTK-KD) was constructed by in-
troducing a point mutation (D664A) in subdomain VII of the catalytic
domain (by analogy with Mps1p; [18]) in pEGFP vector (Clonetch,
Pala Alto, CA) as described [19]. Western blotting analyses using TTK
monoclonal antibody show that exogenously expressed GFP-TTK
protein is 2.3-fold higher than that of endogenous protein. In some
cases, DNA proﬁles of the GFP-TTK (wild type and KD) expressing
cells were determined by FACS analysis 48 h after the transfection as
described [17].
2.4. Immunoﬂuorescence microscopy
For immunoﬂuorescence, cells were seeded onto sterile, acid-treated
18-mm coverslips in 6-well plates (Corning Glass Works, Corning,New York). Double thymidine blocked and released HeLa cells were
transfected with 2 lg/ml lipofectamine 2000 pre-mixed with various
siRNA oligonucleotides as described above. In general, 36–48 h after
transfection with siRNA or scrambled (control) oligonucleotides,
HeLa cells were rinsed for 1 min with PHEM buﬀer (100 mM Pipes, 20
mM HEPES, pH 6.9, 5 mM EGTA, 2 mM MgCl2 and 4 M glycerol)
and were permeabilized for 1 min with PHEM plus 0.2% Triton X-100
as described (e.g., [15,16]). Extracted cells were then ﬁxed in freshly
prepared 4% paraformaldehyde plus 0.05% glutaraldehyde in PHEM,
and rinsed three times in PBS. Cells on the coverslips were blocked
with 0.05% Tween 20 in PBS (TPBS) with 1% BSA (Sigma Chemicals).
These cells were incubated with various primary antibodies in a hu-
midiﬁed chamber for 1 h and then washed three times in TPBS.
Monoclonal antibodies bound to c-tubulin and TTK were visualized
using ﬂuorescein-conjugated goat anti-mouse IgG, respectively, while
binding of TACC2 was visualized using Texas Red-conjugated donkey
anti-rabbit IgG. DNA was stained with 4,6-diamidino-2-phenylindole
(DAPI; Sigma Chemicals). Slides were examined with a Zeiss LSM510
confocal scanning ﬂuorescence microscope and images were collected
and analyzed with Image-5 (Carl Zeiss, Germany).
2.5. Western blot
Samples were subjected to SDS–PAGE on 6–16% gradient gel and
transferred onto nitrocellulose membrane. Proteins were probed by
appropriate primary and secondary antibodies and detected using ECL
(Pierce Chemical). The band intensity was then scanned using a
Phosphoimager (Amersham Bioscience, NJ).3. Results and discussion
3.1. TACC2 is a phospho-protein associated with TTK
Requirement of TTK in spindle checkpoint signaling pro-
pelled us to search for its downstream eﬀectors. We adopted
GFP immunoprecipitation from HeLa cells expressing GFP-
TTK (both wild type and kinase death) followed by mass
spectrometric identiﬁcation of in-gel digested peptide ﬁnger-
print [2,19]. Our preliminary mass spectrometric identiﬁcation
suggested that a polypeptide with approximately 120 kDa is a
TACC2-like protein. To validate if TACC2 is associated with
TTK protein, we probed GFP-TTK immunoprecipitates with
aﬃnity-puriﬁed TACC2 antibody. As shown in Fig. 1A,
TACC2 Western blot veriﬁed that the 120 kDa protein in GFP
immunoprecipitates is indeed TACC2. Careful examination of
the TACC2 Western blot revealed that TACC2 migrates
slower from cells expressing wild type TTK compared to that
of kinase death TTK expressing cells. In addition, fewer
TACC2 was recovered from kinase death TTK expressing cells
compared to that of wild type TTK expressing cells. Probing
same blot with a b-tubulin antibody indicates that TACC2 is
speciﬁcally pulled down by TTK protein. Since TTK protein
remains with diminished kinase activity in early G1 [7], we
sought to validate if TACC2-TTK interaction depends on the
kinase activity. Immunoprecipitation of TTK protein from G1
cell lysates did not pull down any TACC2 protein, indicating
that the TTK-TACC2 interaction is a function of TTK kinase
activation.
To validate if mobility shift of TACC2 is related to TTK
kinase activity, we carried out Western blot of cell lysates from
HeLa cells treated with TTK siRNA oligonucleotide and a
scrambled oligonucleotides. As shown in Fig. 1B, Western blot
with TTK antibody veriﬁed the suppression of endogenous
TTK protein level. Western blotting of TACC2 conﬁrmed that
its mobility shift is a function of TTK protein kinase activity.
Thus, we conclude that the interaction between TACC2 and
TTK is likely a downstream component of the kinase cascade.
Fig. 1. TACC2 is a downstream eﬀector protein of TTK kinase. (A)
Immunoprecipitation of GFP pull down TACC2 from mitotic, but not
G1, HeLa cells expressing GFP-TTK. HeLa cells transfected with
GFP-TTK plasmids (wild type, referred to TTK-WT, and kinase death
mutant, denoted as TTK-KD) for 24 h followed by treatment with 100
nM nocodazole for another 20 h as described in Section 2. After ex-
traction in lysis buﬀer and clariﬁcation by centrifugation, lysates (5
mg) were incubated with 10 lg GFP mouse IgG pre-bound protein A/
G beads. Proteins from starting lysates and Nek2A immunoprecipi-
tates were analyzed by SDS–PAGE and immunoblotting using a GFP
rabbit antibody, TACC2 aﬃnity-puriﬁed antibody, and a b-tubulin
antibody, respectively. In the experiment shown in (A), Western
blotting veriﬁes co-immunoprecipitation of TACC2 and wild type
TTK. The mobility shift of TACC2 seen in SDS–PAGE may reﬂect the
possibility of protein phosphorylation retained from wild type TTK-
expressing cells. No tubulin was detected in GFP immunoprecipitates.
In a separated experiment (right panels in A), Western blotting veriﬁes
that TTK did not bring down any TACC2 protein from interphase
cells (G1 Lys). The mobility shift of TACC2 (G1 vs. mitotic) seen in
SDS–PAGE may reﬂect a diminished TTK kinase activity in inter-
phase cells and kinase death mutant expressing cells, respectively. (B)
Mobility shift of TACC2 protein band is a function of TTK kinase
activity. HeLa cells treated with siRNA oligonucleotide for TTK and
scrambled sequence control, respectively, followed by nocodazole
treatment and solubilization in SDS–PAGE sample buﬀer as described
in Section 2. Aliquots of total cell lysates (35 lg protein) from treated
samples were fractionated on a 6–16% gradient SDS–PAGE followed
by Western analyses with antibodies against TACC2, b-tubulin, and
TTK, respectively. Western blotting with TTK antibody veriﬁed an
eﬀective knock-down in TTK protein accumulation, while probing
with TACC2 antibody validated that the mobility shift of TACC
protein is the function of TTK kinase.
Z. Dou et al. / FEBS Letters 572 (2004) 51–56 533.2. TACC2 is co-localized with TTK to centrosome of mitotic
cells
Previous studies of TTK suggest its primary association with
the kinetochore (e.g., [2,11]) in addition to centrosome.
TACC2 is a centrosomal protein whose function is implicated
in spindle stability (e.g., [20]). To explore the spatial–temporal
relationship of TTK and TACC2 distribution in mitotic cells,
we carried out immunocytochemical studies of HeLa cells us-
ing confocal scanning ﬂuorescence microscope.
To better visualize molecular localization, we adopted a pre-
extraction procedure that allows eﬀective labeling of
kinetochore and centrosomal proteins while preserving ﬁnecyto-structure of mitotic cells [8,15,16]. As shown in Fig. 2,
pre-extracted HeLa cells were stained with a TTK monoclonal
antibody followed by a ﬂuorescein-conjugated secondary an-
tibody, while TACC2 is labeled with an aﬃnity-puriﬁed rabbit
antibody followed by a Texas Red-conjugated secondary an-
tibody. In metaphase cells shown in Fig. 2(c), it is readily
apparent that TACC2 becomes as bright centrosomal staining
located to two opposite poles, which is consistent with a pre-
vious report (e.g., [20]). Double labeling of the same cell with
TTK mouse antibody displayed typical centrosome and kine-
tochore stainings as marked by arrowheads and arrows, re-
spectively (Fig. 2(a)). The centrosomal protein staining of
TTK is reminiscent of TACC2 labeling, which becomes ap-
parent as two merged images generated yellow color (Fig. 2(d),
arrowheads). The superimposition of TACC2 labeling onto
that of TTK at the centrosome validates the early biochemical
interaction between these two proteins.
As we reported in our immuno-electron microscopic studies
[4], TTK dissociates from the kinetochore and traﬃcs to the
centrosomes as sister chromatids separate (Fig. 2(e), arrow-
heads). Labeling of TACC2 from the same cell displays a
typical centrosomal labeling (Fig. 2(g), which is superimposed
onto that of TTK. Given the co-distribution proﬁle of these
two proteins to the centrosome during mitosis and their as-
sociation revealed by the immunoprecipitation, we conclude
that TTK interacts with TACC2 at the centrosome in mitotic
cells.
3.3. TTK kinase activity is essential for the centrosomal
localization of TACC2
TACC2 is implicated in maintaining the stability of mitotic
spindle (e.g., [20]). Since TACC2 mobility shift in SDS–PAGE
is a function of TTK activity, we set to test whether the
centrosomal association of TACC2 is dependent on TTK ac-
tivity. To this end, we introduced wild type and kinase death
TTK into HeLa cells by transfection of GFP-tagged TTK
cDNA constructs. Thirty-six hours after the transfection, cells
were collected and stained for GFP, TACC2 and DNA, re-
spectively. As shown in Fig. 3A, expression of GFP-tagged
TTK revealed a typical centrosomal and kinetochore staining
identical to those of endogenous. As predicted, exogenously
expressed TTK was superimposed to that of TACC2 at the
centrosome of mitotic cells (arrowheads; Fig. 3A(d)), sug-
gesting that expression of exogenous TTK did not interfere
with the localization of TACC2 in HeLa cells.
We next examined whether expression of kinase death TTK
(GFP-TTK-KD) would alter the localization of TACC2 on the
centrosome. Thirty-six hours after the transfection, cells were
collected and stained for GFP, TACC2 and DNA, respec-
tively. As shown in Fig. 3A(e and i), kinase death TTK re-
mains largely associated with the centrosomes with slightly
lower level deposition onto the kinetochores (arrow). How-
ever, double labeling of the same cells with TACC2 revealed no
centrosomal but diﬀused spindle staining (Fig. 3A(g)), sug-
gesting the possible liberation of centrosomal TACC in the
absence of TTK. To test if there was gross alteration of
centrosomal structure arisen from the loss of TTK activity, we
doubly stained the HeLa cells expressing kinase death TTK for
c-tubulin, a founding component for the centrosome biogen-
esis. As shown in Fig. 3A(k), c-tubulin marked a typical
centrosomal staining (arrowheads), suggesting that loss of
centrosomal TACC2 is a speciﬁc consequence of TTK loss. In
Fig. 2. Co-localization of TTK with TACC2 to the centrosomes. This set of montage represents optical images collected from prometaphase and
anaphase of HeLa cells triply stained for rabbit TACC antibody (red), DAPI (blue), mouse TTK antibody (green), and their merged images. In the
prometaphase cell (a–d), TTK displayed a typical centrosomal staining (a, arrowheads) in addition to characteristic kinetochore labeling (arrow). The
chromosome conﬁguration was marked by DAPI staining (b). The TACC2 labeled two bright spots situated at the opposite pole across almost-
aligned chromosomes. Merge indicated that TACC2 is a centrosomal protein superimposed onto that of TTK. Bar: 10 lm. In anaphase cells (e–h),
TTK dissociated from centromeres and concentrated to the centrosomes (arrowheads, e). A merge shows a superimposition of TACC2 to that of
TTK staining at the centrosome but not kinetochore. Bar: 10 lm.
54 Z. Dou et al. / FEBS Letters 572 (2004) 51–56fact, elimination of TTK protein by siRNA-mediated knock-
down validated our observed dislocation of TACC2 in kinase
death TTK expressing cells, while localization of other centr-
osomal proteins such as NuMA remained unaltered (data not
shown). Signiﬁcantly, the distance between the two centro-
somes was markedly reduced in these TTK kinase eliminated
cells (8.1 2.6 lm for kinase death; 7.9 2.5 lm for siRNA-
treatment) than those in control cells (12.5 1.7 lm; listed in
Table 1), consistent with the notion in which TACC2 is im-
portant for maintaining spindle stability [20,21]. Therefore, we
conclude that TTK is essential for localization of TACC2 to
the centrosome.
Elimination of TTK, either by overexpression of kinase
death mutant or siRNA-mediated suppression, revealed typi-
cal phenotypes consistent with failures in both centrosome and
kinetochore including chromosome mis-alignment at meta-
phase (e.g., Fig. 3A(f and f 0), arrows) and lagging chromo-
somes during anaphase (data not shown). These mis-aligned
chromosomes, close to either spindle poles, are marked by
BubR1 (Fig. 3A(h0), arrows) while these centrally positioned
chromosomes were free of BubR1 (Fig. 3A(h0), double-arrow),
indicating that these BubR1-marked chromosomes were not
aligned (e.g., [16]). Even these highly disorganized cells, how-
ever, were capable of eventually exiting mitosis, and we ob-
served many cells in interphase with an aberrant DNA content
(Fig. 3B), a phenotype seen in TACC3-depleted mammalian
cells (e.g., [13]). These observations demonstrate that while
association of TACC2 with the centrosome is essential for
faithful mitosis in HeLa cells, phenotypical change related to
the elimination of centrosomal TACC2 may be compensated
by other TACC proteins given their overlapped localization to
the centrosome. Given the role of TTK in centrosome and
spindle stability maintenance [5], the failure to recruit TACC2
to mitotic centrosome presumably explains, at least in part, the
function of TTK in centrosome dynamics. Future experimen-
tation will clarify the speciﬁc role of TTK-TACC2 interaction
in cell cycling.
Recent studies from Glover and colleagues demonstrated
that centrosomal localization of Drosophila TACC (denoted asD-TACC; the only TACC protein in ﬂies) to the mitotic
spindle and centrosome could occur via distinct mechanisms
[21]. They have showed that inactivation of Aurora-A kinase,
another mitotic kinase located to the centrosomes, diminished
the assembly of D-TACC onto the centrosome but not to the
spindle. In addition, the mutation of D-TACC also nailed
down the localization of MSPS, a microtubule-binding protein
also located to the centrosome [22]. Since MSPS interacts with
D-TACC in vitro and in vivo, it remains to be established
whether loss of centrosomal localization of D-TACC is the
secondary consequence associated with the dislocation of
MSPS arisen from Aurora-A inactivation. Given the fact that
Drosophila Aurora-A interacts with and phosphorylates D-
TACC, it would be important to know whether human Au-
rora-A kinase interacts with TACC2 and whether it is required
for the localization of TACC2 to the centrosome.
Bissell and colleagues have recently isolated TACC2/Azu-1
in a screen aimed for identiﬁcation of stage-speciﬁc tumor
suppressors during tumorigenesis of human breast cancer [14].
They found that TACC2/Azu1 was downregulated not only in
tumorigenic mammary epithelial cells, but also in primary
tumors. The inability to assemble TACC2 protein onto the
centrosome in TTK kinase suppressed cells demonstrated in
our studies suggests that Nek2A kinase may form a link be-
tween TACC2 protein phosphorylation and its role in the
centrosome dynamics and chromosome segregation ﬁdelity.
Given the aberrant expression proﬁle of TTK in human breast
cancer, it would be of great interest to further elucidate the
molecular interaction between TTK and TACC2, and the
precise function of TTK in the centrosome dynamics given its
importance in maintaining chromosome stability.
Taken together, our ﬁnding of the interaction of TTK with
TACC2 demonstrates a critical role of TTK in centrosome
dynamics in addition to its function at mitotic checkpoint. The
fact that suppression of TTK kinase activity disrupts assembly
and/or retention of TACC2 to the centrosome demonstrates
the function and importance of TTK kinase cascade in inte-
grating kinetochore and centrosome dynamics with the mitotic
checkpoint signaling. Our studies presented here open a new
Table 1




SiRNA (TTK) 7.9 2.5
TTK-GFP 13.5 2.3
TTK-KD 8.1 2.6
aDistance between c-tublin-marked centrosomes. Data were obtained
from >100 cells in which both centrosomes were in the same focal
planes (see Section 2).
Fig. 3. The centrosomal localization of TACC2 is dependent on TTK kinase activity. (A) This set of montage represents optical images collected from
HeLa cells triply stained for GFP-TTK wild type (green; TTK-WT, a) and kinase death mutant (green; TTK-KD, e and i), DAPI (blue; b, f, and j),
an aﬃnity rabbit TACC2 antibody (red; c and g), or c-tubulin rabbit antibody (red; g), and their merged images (d, h, and l), respectively. These cells
were transfected with GFT-TTK plasmids (wild type and kinase death) for 36 h followed by ﬁxation and immunocytochemical staining. Wild type
GFP-TTK marked the centromeres the centrosome (arrows) in mitotic cells (a). Overexpression of GFP-TTK kinase death mutant displays a typical
centrosomal and kinetochore staining in addition to deposition onto spindle due to the high expression. Overexpression of TTK-KD caused
chromosome segregation abnormality phenotype also seen in TTK depleted cells. These cells display chromosome mis-alignment and a reduced
distance between two centrosomes. Overexpression of TTK-KD displaced centrosomal localization of TACC2 (arrowheads, g) without alteration of
the centrosomal staining of c-tubulin (arrowheads, k). Lagging and mis-aligned chromosomes were seen in TTK-KD expressing cells (arrow, f, f 0 and
j). Bars: 10 lm. (B) DNA proﬁles of the GFP-positive cells, transfected with wild type kinase and kinase death mutant, were determined by FACS
analysis. Suppression of TTK kinase activity caused a shift of DNA contents. Cells expressing kinase death TTK accumulate with a 4N DNA content
and a signiﬁcant proportion of cells with polyploidy (25.7% compared with 3.5% in control cells expressing wild type TTK).
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trosome dynamics in cell division control.
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